ID   FUT2_RAT                Reviewed;         354 AA.
AC   Q10984; O35087; Q9JK44; Q9R275;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   29-MAY-2024, entry version 144.
DE   RecName: Full=Galactoside alpha-(1,2)-fucosyltransferase 2 {ECO:0000305};
DE   AltName: Full=Alpha 1,2-fucosyltransferase;
DE   AltName: Full=Alpha 1,2-fucosyltransferase B;
DE   AltName: Full=Alpha 1-2 fucosyltransferase;
DE   AltName: Full=Alpha(1,2)FT 2;
DE   AltName: Full=Fucosyltransferase 2;
DE   AltName: Full=GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2;
DE   AltName: Full=Secretor blood group alpha-2-fucosyltransferase;
DE   AltName: Full=Type 1 galactoside alpha-(1,2)-fucosyltransferase FUT2 {ECO:0000305};
DE            EC=2.4.1.69 {ECO:0000269|PubMed:11179967, ECO:0000269|PubMed:11341836};
DE   AltName: Full=Type 2 galactoside alpha-(1,2)-fucosyltransferase FUT2 {ECO:0000305};
DE            EC=2.4.1.344 {ECO:0000269|PubMed:11179967, ECO:0000269|PubMed:11341836};
GN   Name=Fut2 {ECO:0000312|RGD:2639}; Synonyms=Ftb, Sec1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=Fischer;
RX   PubMed=11341836; DOI=10.1021/bi0102104;
RA   Sherwood A.L., Stroud M.R., Levery S.B., Holmes E.H.;
RT   "An amino acid region at the N-terminus of rat hepatoma alpha1-->2
RT   fucosyltransferase modulates enzyme activity and interaction with lipids:
RT   strong preference for glycosphingolipids containing terminal
RT   Galbeta1-->3GalNAc-structures.";
RL   Biochemistry 40:5708-5719(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND TISSUE SPECIFICITY.
RC   STRAIN=BDIX;
RX   PubMed=11179967; DOI=10.1046/j.1432-1327.2001.01962.x;
RA   Bureau V., Marionneau S., Cailleau-Thomas A., Le Moullac-Vaidye B.,
RA   Liehr T., Le Pendu J.;
RT   "Comparison of the three rat GDP-L-fucose:beta-D-galactoside 2-alpha-L-
RT   fucosyltransferases FTA, FTB and FTC.";
RL   Eur. J. Biochem. 268:1006-1019(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Colon cancer;
RA   Soejima M., Wang B., Koda Y., Kimura H.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 222-354 (ISOFORM 2).
RC   STRAIN=BDIX;
RX   PubMed=8010942; DOI=10.1042/bj3000623;
RA   Piau J.-P., Labarriere N., Dabouis G., Denis M.G.;
RT   "Evidence for two distinct alpha(1,2)-fucosyltransferase genes
RT   differentially expressed throughout the rat colon.";
RL   Biochem. J. 300:623-626(1994).
CC   -!- FUNCTION: Catalyzes the transfer of L-fucose, from a guanosine
CC       diphosphate-beta-L-fucose, to the terminal galactose on both O- and N-
CC       linked glycans chains of cell surface glycoproteins and glycolipids and
CC       the resulting epitope regulates several processes such as cell-cell
CC       interaction including host-microbe interaction, cell surface expression
CC       and cell proliferation (PubMed:11179967, PubMed:11341836).
CC       Preferentially fucosylates gangliosides GA1 and GM1 in the antrum,
CC       cecum and colon and in the female reproductive organs. Fucosylated host
CC       glycoproteins or glycolipids mediate interaction with intestinal
CC       microbiota influencing its composition (By similarity). Creates a
CC       soluble precursor oligosaccharide FuC-alpha ((1,2)Galbeta-) called the
CC       H antigen which is an essential substrate for the final step in the
CC       soluble ABO blood group antigen synthesis pathway (PubMed:11179967).
CC       {ECO:0000250|UniProtKB:Q9JL27, ECO:0000269|PubMed:11179967,
CC       ECO:0000269|PubMed:11341836}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl
CC         derivative + GDP-beta-L-fucose = an alpha-L-Fuc-(1->2)-beta-D-Gal-
CC         (1->3)-beta-D-GlcNAc derivative + GDP + H(+); Xref=Rhea:RHEA:50664,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:133506, ChEBI:CHEBI:133509; EC=2.4.1.69;
CC         Evidence={ECO:0000269|PubMed:11179967, ECO:0000269|PubMed:11341836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50665;
CC         Evidence={ECO:0000305|PubMed:11341836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl
CC         derivative + GDP-beta-L-fucose = an alpha-L-Fuc-(1->2)-beta-D-Gal-
CC         (1->4)-beta-D-GlcNAc derivative + GDP + H(+); Xref=Rhea:RHEA:50668,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:133507, ChEBI:CHEBI:133510; EC=2.4.1.344;
CC         Evidence={ECO:0000269|PubMed:11179967, ECO:0000269|PubMed:11341836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50669;
CC         Evidence={ECO:0000305|PubMed:11341836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GM1 (d18:1(4E)) + GDP-beta-L-fucose = a
CC         ganglioside Fuc-GM1 (d18:1(4E)) + GDP + H(+); Xref=Rhea:RHEA:42040,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:77709, ChEBI:CHEBI:78607;
CC         Evidence={ECO:0000269|PubMed:11341836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42041;
CC         Evidence={ECO:0000305|PubMed:11341836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a globoside GalGb4Cer (d18:1(4E)) + GDP-beta-L-fucose = a
CC         globoside Globo-H (d18:1(4E)) + GDP + H(+); Xref=Rhea:RHEA:42044,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:62571, ChEBI:CHEBI:62649;
CC         Evidence={ECO:0000269|PubMed:11341836};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42045;
CC         Evidence={ECO:0000305|PubMed:11341836};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside nLc4Cer + GDP-beta-L-fucose = a neolactoside
CC         IV(2)-alpha-Fuc-nLc4Cer + GDP + H(+); Xref=Rhea:RHEA:48800,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:90376, ChEBI:CHEBI:90803;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48801;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a neolactoside nLc4Cer(d18:1(4E)) + GDP-beta-L-fucose = a
CC         neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) + GDP + H(+);
CC         Xref=Rhea:RHEA:48304, ChEBI:CHEBI:15378, ChEBI:CHEBI:17006,
CC         ChEBI:CHEBI:28691, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48305;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GM1 + GDP-beta-L-fucose = a ganglioside Fuc-GM1
CC         + GDP + H(+); Xref=Rhea:RHEA:48292, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57273, ChEBI:CHEBI:58189, ChEBI:CHEBI:82639,
CC         ChEBI:CHEBI:90189; Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48293;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GA1 + GDP-beta-L-fucose = a ganglioside Fuc-GA1
CC         + GDP + H(+); Xref=Rhea:RHEA:48320, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57273, ChEBI:CHEBI:58189, ChEBI:CHEBI:88069,
CC         ChEBI:CHEBI:90262; Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48321;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GDP-beta-L-fucose + Lc4Cer = alpha-L-fucosyl-(1->2)-beta-D-
CC         galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-
CC         galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide + GDP + H(+);
CC         Xref=Rhea:RHEA:48792, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:90800, ChEBI:CHEBI:90802;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48793;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-
CC         beta-D-Glc-(1<->1')-Cer(d18:1(4E)) + GDP-beta-L-fucose = alpha-L-
CC         fucosyl-(1->2)- beta-D-galactosyl-(1->3)-N-acetyl-beta-D-
CC         glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-
CC         (1<->1')-N-acylsphing-4-enine + GDP + H(+); Xref=Rhea:RHEA:32175,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17292, ChEBI:CHEBI:28743,
CC         ChEBI:CHEBI:57273, ChEBI:CHEBI:58189; EC=2.4.1.69;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32176;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ganglioside GD1b + GDP-beta-L-fucose = a ganglioside Fuc-
CC         GD1b + GDP + H(+); Xref=Rhea:RHEA:48324, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57273, ChEBI:CHEBI:58189, ChEBI:CHEBI:82939,
CC         ChEBI:CHEBI:90265; Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48325;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a lactoside III(4)-a-Fuc-Lc4Cer + GDP-beta-L-fucose = a
CC         lactoside IV(2),III(4)-a-[Fuc]2-Lc4Cer + GDP + H(+);
CC         Xref=Rhea:RHEA:62616, ChEBI:CHEBI:15378, ChEBI:CHEBI:57273,
CC         ChEBI:CHEBI:58189, ChEBI:CHEBI:90811, ChEBI:CHEBI:142612;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62617;
CC         Evidence={ECO:0000250|UniProtKB:Q9JL27};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=beta-D-galactosyl-(1->3)-N-acetyl-D-galactosamine + GDP-beta-
CC         L-fucose = alpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->3)-N-acetyl-
CC         D-galactosamine + GDP + H(+); Xref=Rhea:RHEA:62964,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57273, ChEBI:CHEBI:58189,
CC         ChEBI:CHEBI:84728, ChEBI:CHEBI:546807;
CC         Evidence={ECO:0000250|UniProtKB:Q28113};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62965;
CC         Evidence={ECO:0000250|UniProtKB:Q28113};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=33 mM for phenyl-beta-galactose {ECO:0000269|PubMed:11179967};
CC         KM=20 mM for N-acetyllactosamine {ECO:0000269|PubMed:11179967};
CC         KM=8.3 mM for lacto-N-biose {ECO:0000269|PubMed:11179967};
CC         KM=3.8 mM for galacto-N-biose {ECO:0000269|PubMed:11179967};
CC         KM=24 uM for GDP-fucose {ECO:0000269|PubMed:11179967};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:11179967, ECO:0000269|PubMed:11341836}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane
CC       {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.
CC       Note=Membrane-bound form in trans cisternae of Golgi. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q10984-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q10984-2; Sequence=VSP_016526;
CC   -!- TISSUE SPECIFICITY: Specifically expressed in gut.
CC       {ECO:0000269|PubMed:11179967}.
CC   -!- MISCELLANEOUS: In rat, there are three genes (Fut1/Fta, Fut2/Ftb and
CC       Ftc) which encode galactoside 2-L-fucosyltransferase. They are
CC       expressed in a tissue-specific manner and Ftc may have no enzymatic
CC       activity.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 11 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF264005; AAF72200.1; -; mRNA.
DR   EMBL; AF131238; AAD24469.1; -; Genomic_DNA.
DR   EMBL; AB006138; BAA21742.1; -; mRNA.
DR   EMBL; L26010; AAB41515.1; -; mRNA.
DR   PIR; S46494; S46494.
DR   RefSeq; NP_113823.1; NM_031635.1.
DR   RefSeq; XP_006229197.1; XM_006229135.3.
DR   AlphaFoldDB; Q10984; -.
DR   STRING; 10116.ENSRNOP00000028519; -.
DR   SwissLipids; SLP:000000796; -.
DR   CAZy; GT11; Glycosyltransferase Family 11.
DR   GlyCosmos; Q10984; 1 site, No reported glycans.
DR   GlyGen; Q10984; 1 site.
DR   PhosphoSitePlus; Q10984; -.
DR   PaxDb; 10116-ENSRNOP00000028519; -.
DR   GeneID; 58924; -.
DR   KEGG; rno:58924; -.
DR   UCSC; RGD:2639; rat. [Q10984-1]
DR   AGR; RGD:2639; -.
DR   CTD; 2524; -.
DR   RGD; 2639; Fut2.
DR   eggNOG; ENOG502S316; Eukaryota.
DR   InParanoid; Q10984; -.
DR   OrthoDB; 2959824at2759; -.
DR   PhylomeDB; Q10984; -.
DR   TreeFam; TF315810; -.
DR   BRENDA; 2.4.1.344; 5301.
DR   BRENDA; 2.4.1.69; 5301.
DR   Reactome; R-RNO-9033807; ABO blood group biosynthesis.
DR   Reactome; R-RNO-9037629; Lewis blood group biosynthesis.
DR   Reactome; R-RNO-9840309; Glycosphingolipid biosynthesis.
DR   SABIO-RK; Q10984; -.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:Q10984; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031127; F:alpha-(1,2)-fucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0008417; F:fucosyltransferase activity; ISO:RGD.
DR   GO; GO:0008107; F:galactoside 2-alpha-L-fucosyltransferase activity; IDA:RGD.
DR   GO; GO:0036065; P:fucosylation; IDA:UniProtKB.
DR   GO; GO:0006664; P:glycolipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0009312; P:oligosaccharide biosynthetic process; ISO:RGD.
DR   GO; GO:0006486; P:protein glycosylation; ISO:RGD.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0001936; P:regulation of endothelial cell proliferation; ISS:UniProtKB.
DR   CDD; cd11301; Fut1_Fut2_like; 1.
DR   InterPro; IPR002516; Glyco_trans_11.
DR   PANTHER; PTHR11927; GALACTOSIDE 2-L-FUCOSYLTRANSFERASE; 1.
DR   PANTHER; PTHR11927:SF2; GALACTOSIDE ALPHA-(1,2)-FUCOSYLTRANSFERASE 2; 1.
DR   Pfam; PF01531; Glyco_transf_11; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Lipid metabolism; Membrane; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..354
FT                   /note="Galactoside alpha-(1,2)-fucosyltransferase 2"
FT                   /id="PRO_0000149114"
FT   TOPO_DOM        1..5
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        6..26
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        27..354
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REGION          43..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        199
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         354
FT                   /note="H -> ALTPACPRSHFHLKAKGVTCYVAGRAF (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11341836,
FT                   ECO:0000303|PubMed:8010942"
FT                   /id="VSP_016526"
FT   CONFLICT        26
FT                   /note="T -> I (in Ref. 1 and 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        271
FT                   /note="V -> G (in Ref. 4; AAB41515)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   354 AA;  39983 MW;  123E8C8379E8559E CRC64;
     MASAQVPFSF PLAHFLIFVF VTSTITHLQQ RIVKLQPLSE KELPMTTQMS SGNTESPEMR
     RDSEQHGNGE LRGMFTINSI GRLGNQMGEY ATLFALARMN GRLAFIPASM HNALAPIFRI
     SLPVLHSDTA KKIPWQNYHL NDWMEERYRH IPGHFVRFTG YPCSWTFYHH LRPEILKEFT
     LHDHVREEAQ AFLRGLRVNG SQPSTFVGVH VRRGDYVHVM PNVWKGVVAD RGYLEKALDM
     FRARYSSPVF VVTSNGMAWC RENINASRGD VVFAGNGIEG SPAKDFALLT QCNHTIMTIG
     TFGIWAAYLA GGDTIYLANY TLPDSPFLKV FKPEAAFLPE WVGIPADLSP LLKH
//
